Literature DB >> 10632584

Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.

S L Ingram1, S G Amara.   

Abstract

The dopamine transporter (DAT) exhibits several ionic currents that are either coupled to or uncoupled from the transport of substrate. Second messenger systems have been shown to modulate dopamine (DA) transport, however, the modulation of DAT-associated currents has not been studied in depth. Using the two-electrode voltage-clamp method to record from Xenopus oocytes expressing the human DAT, we examined the effects of arachidonic acid (AA) on membrane currents. AA (10-100 microM) stimulates a novel nonselective cation conductance seen only in oocytes expressing human DA transporter (hDAT). The AA-stimulated conductance is up to 50-fold greater than the current normally elicited by DA, but does not appear to arise from the modulation of previously described hDAT conductances, including the leak current and the current associated with electrogenic transport. In addition, DA dramatically potentiates and cocaine blocks the AA-stimulated DAT current. DA potentiates the AA-induced currents in the absence of sodium and chloride, indicating that these currents arise from processes distinct from those associated with substrate transport. The effects of AA were mimicked by other fatty acids with a rank order of potency correlated with their degree of unsaturation, suggesting that AA directly stimulates the novel cation current. Therefore, AA stimulation of this DAT-associated conductance may provide a novel mechanism for modulation of neuronal signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632584      PMCID: PMC6772426     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Deuterium oxide effects on frog endplate channels.

Authors:  C A Lewis
Journal:  Biophys J       Date:  1984-01       Impact factor: 4.033

2.  Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?

Authors:  C Xu; M E Reith
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

3.  Pore models for transporters?

Authors:  L J DeFelice; R D Blakely
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

4.  Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.

Authors:  M S Sonders; S J Zhu; N R Zahniser; M P Kavanaugh; S G Amara
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

5.  Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.

Authors:  A Volterra; D Trotti; G Racagni
Journal:  Mol Pharmacol       Date:  1994-11       Impact factor: 4.436

6.  Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons.

Authors:  D D Fraser; K Hoehn; S Weiss; B A MacVicar
Journal:  Neuron       Date:  1993-10       Impact factor: 17.173

7.  Synergistic effects of acetylcholine and glutamate on the release of arachidonic acid from cultured striatal neurons.

Authors:  M Tencé; N Murphy; J Cordier; J Prémont; J Glowinski
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

8.  Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism.

Authors:  J Capdevila; L Gil; M Orellana; L J Marnett; J I Mason; P Yadagiri; J R Falck
Journal:  Arch Biochem Biophys       Date:  1988-03       Impact factor: 4.013

9.  Modulation of neuronal calcium channels by arachidonic acid and related substances.

Authors:  H Schmitt; H Meves
Journal:  J Membr Biol       Date:  1995-06       Impact factor: 1.843

10.  Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane.

Authors:  D Trotti; A Volterra; K P Lehre; D Rossi; O Gjesdal; G Racagni; N C Danbolt
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

View more
  9 in total

Review 1.  Arachidonic acid as a bioactive molecule.

Authors:  A R Brash
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Authors:  Aldo A Rodriguez-Menchaca; Ernesto Solis; Krasnodara Cameron; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Arachidonic acid and ion channels: an update.

Authors:  H Meves
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

4.  Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.

Authors:  Weimin C Hong; Susan G Amara
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

5.  Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

Authors:  Dove J Keith; Amy J Eshleman; Aaron Janowsky
Journal:  Eur J Pharmacol       Date:  2010-10-20       Impact factor: 4.432

6.  α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter.

Authors:  Jarod Swant; J Shawn Goodwin; Ashley North; Ahmad Abdul Ali; Joyonna Gamble-George; Sanika Chirwa; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

7.  Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis.

Authors:  Scott V Adams; Louis J DeFelice
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

Review 8.  Close encounters of the oily kind: regulation of transporters by lipids.

Authors:  Christopher B Divito; Susan G Amara
Journal:  Mol Interv       Date:  2009-10

9.  3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

Authors:  Jack W Lipton; Emeline G Tolod; Valerie B Thompson; Lin Pei; Katrina L Paumier; Brian T Terpstra; Kaari A Lynch; Timothy J Collier; Caryl E Sortwell
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.